10/17/2024
3:54 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 15-12G | |
10/04/2024
3:21 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024
3:24 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024
3:27 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024
3:30 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024
3:33 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024
3:36 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024
3:18 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024
3:16 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form POSASR | |
08/27/2024
9:14 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/15/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC 13D/A | |
Get the Latest News and Ratings for MOR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for MorphoSys and its competitors with MarketBeat's FREE daily newsletter. |
08/13/2024
3:31 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
08/07/2024
3:51 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
| Form SC 14D9/A | |
08/07/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
08/05/2024
7:14 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/02/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
08/01/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/31/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/30/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/29/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/25/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/25/2024
3:05 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 25
Notification of the removal from listing and registration of matured, redeemed or retired securities | |
07/18/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/18/2024
10:25 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/12/2024
3:20 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/11/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/05/2024
5:48 AM | MorphoSys (Subject)
MorphoSys AG (Subject)
| Form SC 14D9 | |
07/05/2024
5:02 AM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T | |
07/02/2024
9:18 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/21/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC 13D/A | |
06/21/2024
9:07 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/20/2024
3:41 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/20/2024
3:33 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
| Form SC14D9C | |
06/20/2024
2:38 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-C | |
06/17/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC 13D/A | |
06/10/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC 13D/A | |
06/10/2024
11:06 AM | GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
MorphoSys (Subject)
MorphoSys AG (Subject)
| Form SC 13G/A | |
06/10/2024
10:01 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/06/2024
3:36 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/05/2024
9:22 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/04/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
Trump’s Great Society (Ad) Trump’s Final Reset
Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now. Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma |
06/04/2024
9:17 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/31/2024
9:17 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/29/2024
9:17 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/28/2024
9:16 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/24/2024
9:13 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/23/2024
1:19 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
| Form SC 14D9/A | |
05/23/2024
9:11 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/23/2024
8:04 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/21/2024
9:07 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/17/2024
9:15 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/16/2024
3:43 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
| Form SC 14D9/A | |
05/16/2024
3:31 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
05/16/2024
9:11 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/15/2024
9:09 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/14/2024
9:27 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/13/2024
9:19 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/10/2024
9:31 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/08/2024
9:08 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/07/2024
3:45 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
05/07/2024
9:24 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/06/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
05/06/2024
9:07 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/03/2024
9:29 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/02/2024
3:31 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
05/02/2024
9:43 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/30/2024
9:07 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/30/2024
7:57 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/29/2024
3:15 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/29/2024
9:17 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/26/2024
9:11 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/25/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
04/25/2024
9:38 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/24/2024
10:03 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/23/2024
9:14 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/22/2024
9:32 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/19/2024
9:17 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/18/2024
3:31 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
04/18/2024
1:33 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC 13D | |
04/18/2024
9:13 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/17/2024
3:49 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
| Form SC 14D9/A | |
04/17/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
04/16/2024
4:07 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
04/16/2024
9:12 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/15/2024
2:44 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
04/12/2024
9:54 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/11/2024
10:57 AM | MorphoSys (Subject)
MorphoSys AG (Subject)
| Form SC 14D9 | |
04/11/2024
5:01 AM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T | |
04/09/2024
9:07 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/08/2024
9:19 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/04/2024
9:15 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
New “Trump” currency proposed in DC (Ad) According to one of the most connected men in Washington…
A surprising new bill was just introduced in Washington. Its purpose: to put Donald Trump’s face on the $100 note.
All to celebrate a new “golden age” for America.
 When you see what could happen – I think you’ll be excited. |
04/02/2024
9:08 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/27/2024
12:16 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/26/2024
10:15 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
